Modern
Medicines:
New Perspectives in Pharmaceutical History
October 17-18, 2008
American Institute of the History of Pharmacy
Rennebohm Hall
University of Wisconsin
Madison, WI
53705
Email: conference@aihp.org
The evolution
of the modern pharmaceutical enterprise over the long twentieth
century—from its early intersection with the image and later the
structure of scientific research, to its dramatic postwar expansion and
late-century saturation of medical and marketing media—has implications
that stretch far beyond the traditional history of pharmacy and medicine to
impact broader social, cultural, economic, business, legal, regulatory,
and political developments. This conference seeks to foster and reflect
on the growing body of pharmaceutical scholarship across historical disciplines
and encourage novel theoretical and methodological developments by featuring
newer scholars alongside more established figures in the field.
Some travel
funds will be available for graduate students, and established scholars
interested in using the resources of the American Institute of the History of
Pharmacy can apply for travel funds through the Sonnedecker Visiting Scholar
Program of the UW-Madison School of Pharmacy (click here for Special Sonnedecker Grants for Visiting Researchers
information). AIHP Conference Planning Committee: Jeremy Greene, Dominique
Tobbell, Arthur Daemmrich, Michael Flannery, Elaine Stroud, and Greg Higby.
Registration $95
(includes all conference activities including reception, Continental breakfast,
coffee breaks, lunch workshop, and dinner). For registration forms and program
information, please check the website <www.aihp.org> for updates.
PRELIMINARY PROGRAM
Friday, October
17
3 PM
Introduction and
Welcome
Keynote
Address: Elizabeth Siegel
Watkins
4 – 5:30 PM
Welcome Reception
at the Ebling Library Rare Book Room
Saturday, October
18
8:30 –
10:30 AM
Panel 1: Research
and Development
Judy Slinn (Strategy and structure in the pharmaceutical industry
1945-2007; The rise and fall of a business model?)
Viviane Quirk (From Laboratory Life to National Systems of
Innovation: Culture as a tool for Understanding the Evolution of the
Pharmaceutical Industry in the Twentieth Century)
Christoph Gradmann, (Magic Bullets and Moving Targets: Antibiotic
Resistance before the Event 1900-1940)
Nicolas Rasmussen, (Understanding
Allied Amphetamine Use in the Second World War)
10:45 –
12:15
Panel 2: Regulation and
Governance
Mary Schaeffer Conroy, (State-owned Soviet Pharmaceutical Enterprises)
Daniel P. Carpenter and Dominique Tobbell, (The Emergence and Legacy of Bioequivalence)
Shera Moxley, (Odyssey of a Biotech Drug: Leukine, 1981-1993)
12:15 –
2:15 PM
Lunch Roundtable:
Pharmaceutical History Methodology
Frank R. Lichtenberg, (The Effect of Chemotherapy Innovation on Cancer Survival, 1991-2003)
Benoit Majerus, (How Patients Experience the Introduction of
Psychoactive Drugs, 50s and 60s)
Maki Umemura, (Between Two Cultures: Banyu Pharmaceutical Co.,
1915-2004)
Michael Oldani, (A Brief history (anthropological) of Critical Pharmacy
Studies)
2:30- 4:15 PM
Panel 3: Pharmaceutical
Marketing
Andrew Godley, (Merck and the Emergence of Ethical Marketing in
Pharmaceuticals)
David Herzberg, (Direct to consumer advertising)
Kalman Applbaum, (Adoption of the Circulatory Model for Product
Development and Dissemination in the Pharmaceutical Industry)
Matthew Hersch, (Marketing Stelazine to Disturbed America, 1958-1980)
4:30-5:30 PM
Summary Session
Harry M. Marks, (The
Secret Lives of Drugs: What are
the questions? What are the
answers?)
Dominique Tobbell,
Jeremy Greene,
Arthur Daemmrich, (Wrap-up comments from session chairs)
7:30 PM
Informal Dinner
at Wisconsin historic Red Gym